Evidence map›Paper›PMID 41692956›Full record

ArticleBioinformatics (Oxford, England)2026

AutoFlow: an interactive Shiny app for supervised and unsupervised flow cytometry analysis.

Freya E R Woods, Emilyanne Leonard, Timothy Ebbels, Jonathan Cairns, Rhiannon David

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Freya E R WoodsSafety Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Trumpington, Cambridge, CB2 0AA, United Kingdom.ORCID 0000-0001-9412-0967
Emilyanne LeonardIntegrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Trumpington, Cambridge, CB2 0AA, United Kingdom.
Timothy EbbelsSection of Bioinformatics, Department of Metabolism, Digestion & Reproduction, Imperial College London, London, W12 0NN, United Kingdom.
Jonathan CairnsData Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Trumpington, Cambridge, CB2 0AA, United Kingdom.
Rhiannon DavidSafety Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Trumpington, Cambridge, CB2 0AA, United Kingdom.

Funding

AstraZeneca
6 · The paper itself

Abstract

motivationFlow cytometry (FC) is a widely used technique for analysing cells or particles based on the fluorescence of specific markers. Thresholds for fluorescence are typically set manually, a laborious, subjective process that scales poorly as FC technology advances. Machine learning (ML) methods can address these issues but often require technical expertise many bench scientists do not possess. Thus, accessible, open-source, and cross-domain ML-based FC tools are needed.

resultsWe present AutoFlow, an easy-to-use, adaptable R Shiny application for automated flow cytometry (FC) analysis. AutoFlow supports two workflows: supervised and unsupervised learning. The application automates key preprocessing steps including fluorescence compensation, debris exclusion, single-cell identification, viability marker gating, and downstream classification or clustering. Across three datasets, two publicly available (Mosmann and Nilsson Rare) and a novel bone marrow microphysiological system (BM-MPS) dataset, AutoFlow demonstrated robust performance. In the supervised workflow, multiclass classification on BM-MPS achieved 97.2% accuracy under a single-timepoint training and multi-timepoint testing scheme, with high sensitivity and specificity across major lineages. For rare populations, performance was strong: Mosmann Rare (0.03% prevalence) achieved 87.5% sensitivity, and 100% specificity, while Nilsson Rare (0.08% prevalence) achieved 87.9% sensitivity, and 99.9% specificity. The unsupervised workflow accurately grouped cells into biologically meaningful clusters, recovering known populations and identifying additional candidate populations with marker profiles consistent with true biology. AutoFlow offers a fast, reproducible, and scalable solution for FC analysis, enabling high-throughput studies and improving the discovery of rare or unexpected cell types. AVAILABILITY AND IMPLEMENTATION: The application is available at https://github.com/FERWoods/AutoFlow for download using R. An archived version is available at DOI: 10.5281/zenodo.18235796.

Indexed as

Flow CytometrySoftwareSupervised Machine LearningUnsupervised Machine LearningClustering AlgorithmsHumans

Identifiers

PMID41692956
PMCPMC12970595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.